ZB
ZBH
Year ended Dec 31, 2024 · FY2025 10-K

Zimmer Biomet Holdings (ZBH) 10-K Summary — Year Ended Dec 31, 2024

The company reported revenue growth and positive operating income and net income, though operating cash flow decreased compared to the prior year. The filing discusses liquidity resources and ongoing investments.

Key takeaway

Year ended Dec 31, 2024 · FY2025 10-K

The company reported revenue growth and positive operating income and net income, though operating cash flow decreased compared to the prior year. The filing discusses liquidity resources and ongoing investments.

Financial snapshot

Selected annual figures reported with the filing, shown separately from the narrative summary.

Annual revenue

$7.7B

Revenue reported for the fiscal year.

Operating income

$1.3B

Income from operations reported for the year.

Net income

$903.8M

Net income reported for the year.

Operating cash flow

$1.5B

Cash generated by operating activities.

Annual revenue trend

Reported annual revenue and its change from the preceding fiscal year.

Period endedRevenueYear-over-year change
Dec 31, 2021$6.8Bn/a
Dec 31, 2022$6.9B+1.6%
Dec 31, 2023$7.4B+6.5%
Dec 31, 2024$7.7B+3.8%

Business overview

The filing does not include a description of the company's business operations. The Business overview section is referenced but no substantive text is provided.

Financial performance

Reported revenue increased over the most recent periods. Operating income and net income were positive, and operating cash flow was generated but lower than the preceding year.

Material risks

The filing references risk factors but does not provide specific risk descriptions in the supplied context. No material risks are explicitly stated.

Liquidity and capital

The company maintains cash and cash equivalents and has access to revolving credit facilities. Management believes these sources, along with operating cash flows, are sufficient to meet liquidity needs. Cash used in investing activities included investments in instruments and property and equipment.

What to watch

Monitor the trend in operating cash flow, as it decreased compared to the prior year, and the company's ability to maintain sufficient liquidity.

Zimmer Biomet Holdings (ZBH) 10-K Summary — Year Ended Dec 31, 2024